94 related articles for article (PubMed ID: 3379102)
21. Characterization of the rebinding of 125I-epidermal growth factor released from BALB/c-3T3 cells following accumulation in the presence of chloroquine.
Cooper JL; Wakshull E; Wharton W
J Cell Physiol; 1988 Mar; 134(3):387-95. PubMed ID: 3258311
[TBL] [Abstract][Full Text] [Related]
22. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
23. Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells.
Zheng ZS; Goldsmith LA
Cancer Res; 1990 Feb; 50(4):1201-5. PubMed ID: 2297769
[TBL] [Abstract][Full Text] [Related]
24. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase C inhibits epidermal growth factor receptor phosphorylation in enterocytes.
Summers ST; Bass BL
J Surg Res; 1997 Apr; 69(1):208-11. PubMed ID: 9202672
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin F2 alpha inhibits epidermal growth factor binding to cellular receptors on adipocyte precursors in primary culture.
Serrero G; Lepak NM
Biochem Biophys Res Commun; 1995 Jul; 212(3):1125-32. PubMed ID: 7626101
[TBL] [Abstract][Full Text] [Related]
27. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
28. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
30. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
32. Bovine brain-derived growth factor. Purification and characterization of its interaction with responsive cells.
Huang JS; Huang SS; Kuo MD
J Biol Chem; 1986 Sep; 261(25):11600-7. PubMed ID: 3017935
[TBL] [Abstract][Full Text] [Related]
33. Use of selective tyrosine kinase blockers to monitor growth factor receptor dephosphorylation in intact cells.
Böhmer FD; Böhmer A; Obermeier A; Ullrich A
Anal Biochem; 1995 Jul; 228(2):267-73. PubMed ID: 8572305
[TBL] [Abstract][Full Text] [Related]
34. Mitogenic and metabolic actions of epidermal growth factor on rat articular chondrocytes: modulation by fetal calf serum, transforming growth factor-beta, and tyrphostin.
Ribault D; Khatib AM; Panasyuk A; Barbara A; Bouizar Z; Mitrovic RD
Arch Biochem Biophys; 1997 Jan; 337(2):149-58. PubMed ID: 9016808
[TBL] [Abstract][Full Text] [Related]
35. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
Lockyer JM; Bowden GT; Matrisian LM; Magun BE
Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
[TBL] [Abstract][Full Text] [Related]
36. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
[TBL] [Abstract][Full Text] [Related]
37. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
38. Regulation of motility in bovine brain endothelial cells.
Rosen EM; Jaken S; Carley W; Luckett PM; Setter E; Bhargava M; Goldberg ID
J Cell Physiol; 1991 Feb; 146(2):325-35. PubMed ID: 1825664
[TBL] [Abstract][Full Text] [Related]
39. Effects of 12-O-tetradecanoylphorbol-13-acetate on epidermal growth factor receptors in BALB/c-3T3 cells: relationship between receptor modulation and mitogenesis.
Selinfreund R; Wharton W
Cancer Res; 1986 Sep; 46(9):4486-90. PubMed ID: 3015388
[TBL] [Abstract][Full Text] [Related]
40. Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors.
Masui H; Wells A; Lazar CS; Rosenfeld MG; Gill GN
Cancer Res; 1991 Nov; 51(22):6170-5. PubMed ID: 1933876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
